Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
5 Best Biotech Stocks To Buy For 2021
5. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
Vertex Pharmaceuticals (NASDAQ: VRTX) is a Boston-based firm that aims to develop and manufacture transformative medicine for people with serious diseases. It has a market cap of well over $55 billion and generates an annual revenue of well over $6 billion. In fact, in 2020, the revenue soared 50% compared to the previous year. The company enjoys a monopoly in treating cystic fibrosis and presently markets four drugs related to the disease. A new drug in this group has soared to incredible highs in the US and is now slated for worldwide growth.
Vertex Pharmaceuticals Incorporated: Vertex Receives CHMP Positive Opinion for KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat People With Cystic Fibrosis With At Least One F508del Mutation finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Here’s Why Vertex (VRTX) Landed in Alger Spectra’s Detractor List
Alger, an investment management firm, published its ‘Alger Spectra Fund’ fourth quarter 2020 investor letter – a copy of which can be downloaded here. In the letter, the fund highlighted their largest portfolio sector weightings, which is in Information Technology and Consumer Discretionary sector, with their comments on notable companies. The Communication Services sector together with the Industrial sector is where they achieved the largest chunk of their returns. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Alger Spectra Fund, in their Q4 2020 investor letter, mentioned Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and emphasized their views on the company. Vertex Pharmaceuticals Incorporated is a Boston, Massachusetts-based biopharmaceutical company that currently has a $57.1 billion market capitalization. Since the beginning of the year, VRTX delivered a -7.
Vertex Reports FDA Fast Track Designation For VX-880 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.